DUBLIN--(BUSINESS WIRE)--Crescent Diagnostics Ltd (“Crescent”) has launched Osentia™, a new convenient screening test which identifies those at risk of fragility fracture by analysing finger or toe nail clippings. Launching in the UK, Osentia™ is available online and will shortly be available direct from pharmacies. The test enables consumers to identify their level of risk of suffering a fragility fracture due to osteoporosis. Using this information, consumers can initiate long term lifestyle changes and access appropriate therapeutic intervention, which can help avoid serious osteoporosis-related fractures in later life.
Help employers find you! Check out all the jobs and post your resume.
